Concepedia

Bin Wu

BW

Statistics

Publications

37

Citations

1.2K

H-Index

22

Active since

1992

Affiliations

Amgen (United States)(Current)

University of Utah

China Pharmaceutical University

China Astronaut Research and Training Center

Bin Wu is an author at Amgen (United States) specializing in pharmacology, drug discovery, and pharmacy.

Publications per year

1992–2022

37

Publications

37

Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism

Elizabeth A. Killion, Michelle Chen, James R. Falsey et al. · Nature Communications · 2020 · 136 citations · Full text

Medicine, Endocrinology, Pharmacology +17

A strategy for screening of high-quality enzyme inhibitors from herbal medicines based on ultrafiltration LC-MS and in silico molecular docking

Hui‐Peng Song, Jun Chen, Jia-Ying Hong et al. · Chemical Communications · 2014 · 88 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Pyrimidine nucleotides suppress K<sub>DR</sub>currents and depolarize rat cerebral arteries by activating Rho kinase

Kevin D. Luykenaar, Suzanne E. Brett, Bin Wu et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2004 · 65 citations

Medicine, Pharmacology, Physiology +12

Selective Class I Phosphoinositide 3-Kinase Inhibitors: Optimization of a Series of Pyridyltriazines Leading to the Identification of a Clinical Candidate, AMG 511

Mark H. Norman, Kristin L. Andrews, Yunxin Bo et al. · Journal of Medicinal Chemistry · 2012 · 50 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V

Bryan D. Moyer, Justin K. Murray, Joseph Ligutti et al. · PLoS ONE · 2018 · 49 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

1–5 of 37